4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine

C99H122N16OS3 — CID 162188154

IUPAC4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine
SMILESCCN(CC)c1nc2ccccc2n1CC.CN(C)CCc1c[nH]c2ccccc12.CN(C)Cc1c[nH]c2ccccc12.CN(C)Cc1cccs1.CN(C)c1ccc(C=Cc2nc3ccccc3s2)cc1.CNCCc1c[nH]c2ccccc12.COc1ccc2[nH]cc(CN(C)C)c2c1.Cc1ccc2nc(-c3ccc(N(C)C)cc3)sc2c1
InChIInChI=1S/C17H16N2S.C16H16N2S.C13H19N3.C12H16N2O.C12H16N2.2C11H14N2.C7H11NS/c1-19(2)14-10-7-13(8-11-14)9-12-17-18-15-5-3-4-6-16(15)20-17;1-11-4-9-14-15(10-11)19-16(17-14)12-5-7-13(8-6-12)18(2)3;1-4-15(5-2)13-14-11-9-7-8-10-12(11)16(13)6-3;1-14(2)8-9-7-13-12-5-4-10(15-3)6-11(9)12;1-14(2)8-7-10-9-13-12-6-4-3-5-11(10)12;1-13(2)8-9-7-12-11-6-4-3-5-10(9)11;1-12-7-6-9-8-13-11-5-3-2-4-10(9)11;1-8(2)6-7-4-3-5-9-7/h3-12H,1-2H3;4-10H,1-3H3;7-10H,4-6H2,1-3H3;4-7,13H,8H2,1-3H3;3-6,9,13H,7-8H2,1-2H3;3-7,12H,8H2,1-2H3;2-5,8,12-13H,6-7H2,1H3;3-5H,6H2,1-2H3
InChIKeyZPXXGOQKSRWYKF-UHFFFAOYSA-N
MW1648.38 g/mol
LogP22.25
Rot. Bonds22

About 4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine

4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine (PubChem CID 162188154) has the molecular formula C99H122N16OS3 and a molecular weight of 1648.38 g/mol. Its IUPAC name is 4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine.

Molecular Properties

Compound Name4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine
PubChem CID162188154
Molecular FormulaC99H122N16OS3
Molecular Weight1648.38 g/mol
Exact Mass1646.91
IUPAC Name4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine
SMILESCCN(CC)c1nc2ccccc2n1CC.CN(C)CCc1c[nH]c2ccccc12.CN(C)Cc1c[nH]c2ccccc12.CN(C)Cc1cccs1.CN(C)c1ccc(C=Cc2nc3ccccc3s2)cc1.CNCCc1c[nH]c2ccccc12.COc1ccc2[nH]cc(CN(C)C)c2c1.Cc1ccc2nc(-c3ccc(N(C)C)cc3)sc2c1
InChIInChI=1S/C17H16N2S.C16H16N2S.C13H19N3.C12H16N2O.C12H16N2.2C11H14N2.C7H11NS/c1-19(2)14-10-7-13(8-11-14)9-12-17-18-15-5-3-4-6-16(15)20-17;1-11-4-9-14-15(10-11)19-16(17-14)12-5-7-13(8-6-12)18(2)3;1-4-15(5-2)13-14-11-9-7-8-10-12(11)16(13)6-3;1-14(2)8-9-7-13-12-5-4-10(15-3)6-11(9)12;1-14(2)8-7-10-9-13-12-6-4-3-5-11(10)12;1-13(2)8-9-7-12-11-6-4-3-5-10(9)11;1-12-7-6-9-8-13-11-5-3-2-4-10(9)11;1-8(2)6-7-4-3-5-9-7/h3-12H,1-2H3;4-10H,1-3H3;7-10H,4-6H2,1-3H3;4-7,13H,8H2,1-3H3;3-6,9,13H,7-8H2,1-2H3;3-7,12H,8H2,1-2H3;2-5,8,12-13H,6-7H2,1H3;3-5H,6H2,1-2H3
InChIKeyZPXXGOQKSRWYKF-UHFFFAOYSA-N
XLogP22.25
TPSA150.70 Ų
H-Bond Donors5
H-Bond Acceptors16
Rotatable Bonds22
Heavy Atoms119
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001648.38
LogP ≤ 522.25
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_B(251)', 'substructure': 'N/A'}, {'alert_name': 'anil_di_alk_G(9)', 'substructure': 'N/A'}

Analyze 4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine?
The IUPAC name of 4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine (CID 162188154) is 4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine.
What is the SMILES notation for 4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine?
The canonical SMILES for 4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine is CCN(CC)c1nc2ccccc2n1CC.CN(C)CCc1c[nH]c2ccccc12.CN(C)Cc1c[nH]c2ccccc12.CN(C)Cc1cccs1.CN(C)c1ccc(C=Cc2nc3ccccc3s2)cc1.CNCCc1c[nH]c2ccccc12.COc1ccc2[nH]cc(CN(C)C)c2c1.Cc1ccc2nc(-c3ccc(N(C)C)cc3)sc2c1.
What is the InChIKey of 4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine?
The InChIKey is ZPXXGOQKSRWYKF-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H16N2S.C16H16N2S.C13H19N3.C12H16N2O.C12H16N2.2C11H14N2.C7H11NS/c1-19(2)14-10-7-13(8-11-14)9-12-17-18-15-5-3-4-6-16(15)20-17;1-11-4-9-14-15(10-11)19-16(17-14)12-5-7-13(8-6-12)18(2)3;1-4-15(5-2)13-14-11-9-7-8-10-12(11)16(13)6-3;1-14(2)8-9-7-13-12-5-4-10(15-3)6-11(9)12;1-14(2)8-7-10-9-13-12-6-4-3-5-11(10)12;1-13(2)8-9-7-12-11-6-4-3-5-10(9)11;1-12-7-6-9-8-13-11-5-3-2-4-10(9)11;1-8(2)6-7-4-3-5-9-7/h3-12H,1-2H3;4-10H,1-3H3;7-10H,4-6H2,1-3H3;4-7,13H,8H2,1-3H3;3-6,9,13H,7-8H2,1-2H3;3-7,12H,8H2,1-2H3;2-5,8,12-13H,6-7H2,1H3;3-5H,6H2,1-2H3.
What are the key properties of 4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine?
4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine has a molecular weight of 1648.38 g/mol, XLogP of 22.25, 22 rotatable bonds, 5 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-dimethylaniline;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline;N,N-dimethyl-1-thiophen-2-ylmethanamine;2-(1H-indol-3-yl)-N,N-dimethylethanamine;1-(1H-indol-3-yl)-N,N-dimethylmethanamine;2-(1H-indol-3-yl)-N-methylethanamine;1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine;N,N,1-triethylbenzimidazol-2-amine is sourced from PubChem (CID 162188154), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).